PGEN (Precigen Inc) Yalpi foyda marjasi

Precigen Inc (PGEN) kompaniyasining rasmiy ramzlari

Precigen, Inc. (PGEN) o'z obro'sini kam uchraydigan patologiyalar bo'yicha inqilobiy hujayra tadqiqotlariga asoslaydi. GURU.Markets tizimi mediana yalpi foyda marjasini hisoblaydi, bunda 90.60 qiymati ushbu metrikaning balansini aks ettiradi. Precigen, Inc. (PGEN) shaxsiy platformalardan foydalangan holda diabet va onkologiya bemorlari uchun sintetik biologiya bozorini rivojlantirmoqda. Strategiya UltraCAR-T platformasiga tayanadi, u bevosita klinikalarda shaxsiylashtirilgan terapiyalarni yaratishni tezlashtiradi.

Precigen (PGEN): Yalpi marja 04.07.2022dan 20.11.2026gacha

Precigen Inc (PGEN) moliyaviy va bozor koʻrsatkichlari kesimi

- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Intrexon
Precigen original mahsuloti

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlarini qoplashdan keyin qolgan daromad qismini o'lchaydi, bu esa emitentning xarajatlarni boshqarish samaradorligi va narxlarni belgilash imkoniyatlarini aks ettiradi. Geopolitik fragmentatsiya va biokomponentlar uchun sanktsiya to'siqlari sharoitida Precigen, Inc. operatsion samaradorlikning pasayishini boshdan kechirishi mumkin; shuning uchun, yalpi foyda marjasi koeffitsientini tahlil qilish investorlarga kapitalning suyulish xatarlarini o'z vaqtida aniqlash imkonini beradi.

Muhim raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PHAR - Yalpi rentabellik|Yalpi foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Yalpi foyda bo'yicha rentabellik|Zenas Corp (ZBIO) - Yalpi marja|Yalpi foyda bo'yicha rentabellik IMNM|GOSS: Yalpi foyda normasi|Yalpi rentabellik KalVista Pharma (KALV)|SEPN - Yalpi foyda marjasi|Yalpi marja PVLA (pieris.com)|Yalpi marja Savara Pharma SVRA|RIGL: Yalpi foyda bo'yicha rentabellik|ANAB - Yalpi marja|ATXS: Yalpi marja|ENGN - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik